Publication Author: Weatherald J
Filter by Author:
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.
Budhram B, Alrasheed SK, Rashad M, Chandy G, Dvorkin-Gheva A, Fox GA, Foxall J, Gardner A, Helmersen D, Hirani N, Kemp K, Kularatne M, Langleben D, Lesenko L, Provencher S, Spence E, Swiston JR, Thakrar M, Wadden D, Weatherald J, Hambly N.
Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.
Grynblat J, Hlavaty A, Savale L, Weatherald J, Le Bozec A, Aguado B, Chaumais MC, Humbert M, Khouri C, Montani D.
Authors’ Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
Sahay S, Visovatti S, Tonelli AR, Villasmil Hernandez N, Austin ED, Badagliacca R, Berger RMF, Boucly A, Chen Y, Church C, Delcroix M, Everett AD, Farber HW, Fauvel C, Gomberg-Maitland M, Griffiths M, Haddad F, Han Y, Hemnes A, Hoeper MM, Kanwar MK, Lachant D, Murthy S, Olsson KM, Preston I, Rådegran G, Sitbon O, Trivieri MG, Vachiery JL, Vanderpool R, Weatherald J, White RJ, Whitford H, Wilson M, L Benza R.
Exploring the temporal relationship between stigma, disease manifestations, and health outcomes in post COVID-19 condition: a longitudinal descriptive study.
Damant RW, Rourke L, Lam GY, Smith MP, Weatherald J, Laratta CR, Fuhr DP, Cui Y, Stickland MK, Ferrara G.
Individually Tailored Physiotherapy in Persons With Respiratory Symptoms Related to Post-Acute Sequelae of COVID-19: A Feasibility Study With Mixed Methods.
Lo M, Eiriksson L, Hunter S, Twomey R, Skolnik K, Chen J, Afshar EE, Weatherald J, Lim RK.
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
Sahay S, Visovatti S, Tonelli AR, Villasmil Hernandez N, Austin ED, Badagliacca R, Berger RMF, Boucly A, Chen Y, Church C, Delcroix M, Everett AD, Farber HW, Fauvel C, Gomberg-Maitland M, Griffiths M, Haddad F, Han Y, Hemnes A, Hoeper MM, Kanwar MK, Lachant D, Murthy S, Olsson KM, Preston I, Rådegran G, Sitbon O, Trivieri MG, Vachiery JL, Vanderpool R, Weatherald J, White RJ, Whitford H, Wilson M, L Benza R.
Platelet Activation on Lung Function During Ex Vivo Lung Perfusion, Lung Transplantation, and the Role of Antiplatelet Therapy: A Narrative Review.
El-Andari R, Kang JJH, Fialka NM, Weatherald J, Alavi P, Jahroudi N, Freed DH, Nagendran J.
Priorities for lung transplantation research: a James Lind Alliance priority-setting partnership between patients, caregivers, and clinicians in Canada.
Michaels MI, Halloran K, Harper L, Marks N, Bergeron C, Nasir B, Kabbani D, van den Bosch L, Hirji A, Varughese RA, Weatherald J.
En Bloc Heart-Lung Transplantation: Past and Present. A Systematic Review.
El-Andari R, Fialka NM, Alam A, Khonde I, Weatherald J, Halloran K, Nagendran J.
Respiratory Viruses at Time of Lung Transplant and the Relationship to Primary Graft Dysfunction.
van den Bosch L, Kaur K, Varughese R, Hirji A, Weatherald J, Weinkauf J, Lien D, Garcia OF, Alvarez CC, Doucette K, Kabbani D, Halloran K.
Impact of COVID-19 Pandemic on Interstitial Lung Disease Healthcare Utilization & Outcomes: A Population Study in Alberta, Canada.
Weatherald J, Wen C, Johannson K, Ronksley PE, Bakal JA, Stickland MK, Gross DP, Lam GY.
Impact of COVID-19 pandemic on sex disparities in asthma healthcare utilisation and outcomes: a population study.
Lam GY, Wen C, Ronksley PE, Bakal JA, Bhutani M, Soril LJJ, Stickland MK, Gross DP, Sharpe H, Weatherald J.
Pulmonary arterial hypertension and targeting pulmonary vascular remodelling: are we there yet?
Lordan J, Weatherald J.
An Interpretive Description of Patient and Provider Perspectives on the Impact of the COVID-19 Pandemic on Lung Transplant Care Access and Service Delivery in Alberta, Canada.
Brehon K, Hung P, Miciak M, Varughese R, Halloran K, Perreault K, Ronksley PE, Stickland MK, Weatherald J, Gross DP, Lam GY.
Drugs targeting novel pathways in pulmonary arterial hypertension.
Sitbon O, Boucly A, Weatherald J, Antigny F, Guignabert C, Jevnikar M, Jaïs X, Price LC, Wilkins MR, Zamanian RT, Savale L, Montani D, Humbert M.
Living with cystic fibrosis during the COVID-19 pandemic: An interpretive description of healthcare access from patients with cystic fibrosis and their providers in Alberta, Canada.
Brehon K, Hung P, Miciak M, Leung WM, Perreault K, Gross DP, Weatherald J, Ronksley PE, Stickland MK, Lam GY.
Lung Transplantation From Donors With a History of Substance Use.
Li D, Weinkauf J, Hirji A, Weatherald J, Varughese R, van den Bosch L, Lien D, Nagendran J, Halloran K.
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.
Rahaghi FF, Humbert M, Hoeper MM, White RJ, Frantz RP, Hassoun PM, Hemnes AR, Kawut SM, McLaughlin VV, Meszaros G, Mol PGM, Nathan SD, Psotka MA, Rahaghi FN, Sitbon O, Stockbridge N, Weatherald J, Zannad F, Sahay S.
Awake Prone Positioning in Adults With COVID-19: An Individual Participant Data Meta-Analysis.
Luo J, Pavlov I, Tavernier E, Perez Y, Kharat A, McNicholas B, Roca O, Vines DL, Ibarra-Estrada M, Alhazzani W, Lewis K, Simpson SQ, Rampon G, Liu L, Sun Q, Qiu H, Yang Y, Lapadula G, Qian ET, Gatto CL, Rice TW, Parhar KKS, Weatherald J, Walkey AJ, Bosch NA, Nay MA, Boulain T, Fossat G, Harris TRE, Thwaites CL, Phong NT, Bonfanti P, Yarahmadi S, Hashemian SM, Jayakumar D, Taylor SP, Johnson SA, Guerin C, Laffey JG, Ehrmann S, Li J; Awake Prone Positioning Meta-Analysis Group.
Pulmonary capillary blood volume and diffusing membrane capacity during exercise in humans: role of pulmonary artery pressure.
D'Souza AW, Brotto AR, Hicks B, Bok E, Weatherald J, Van Diepen S, Stickland MK.
